147 related articles for article (PubMed ID: 8957240)
1. The naphtosultam derivative RP 62203 (fananserin) has high affinity for the dopamine D4 receptor.
Heuillet E; Petitet F; Mignani S; Malleron JL; Lavayre J; Néliat G; Doble A; Blanchard JC
Eur J Pharmacol; 1996 Oct; 314(1-2):229-33. PubMed ID: 8957240
[TBL] [Abstract][Full Text] [Related]
2. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
3. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.
Noda-Saita K; Matsumoto M; Hidaka K; Hatanaka K; Ohmori J; Okada M; Yamaguchi T
Biochem Biophys Res Commun; 1999 Feb; 255(2):367-70. PubMed ID: 10049714
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of the dopamine D4 receptor, serotonin 5-HT2A receptor and alpha-1 adrenoceptor antagonist (R)-(+)-2-amino-4-(4-fluorophenyl)-5-[1-[4-(4-fluorophenyl)-4-oxobutyl] pyrrolidin-3-yl]thiazole (NRA0045).
Okuyama S; Chaki S; Yoshikawa R; Suzuki Y; Ogawa S; Imagawa Y; Kawashima N; Ikeda Y; Kumagai T; Nakazato A; Nagamine M; Tomisawa K
J Pharmacol Exp Ther; 1997 Jul; 282(1):56-63. PubMed ID: 9223539
[TBL] [Abstract][Full Text] [Related]
6. Iloperidone binding to human and rat dopamine and 5-HT receptors.
Kongsamut S; Roehr JE; Cai J; Hartman HB; Weissensee P; Kerman LL; Tang L; Sandrasagra A
Eur J Pharmacol; 1996 Dec; 317(2-3):417-23. PubMed ID: 8997630
[TBL] [Abstract][Full Text] [Related]
7. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.
Pugsley TA; Shih YH; Whetzel SZ; Zoski K; Van Leeuwen D; Akunne H; Mackenzie R; Heffner TG; Wustrow D; Wise LD
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):219-26. PubMed ID: 11817497
[TBL] [Abstract][Full Text] [Related]
8. Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.
López-Giménez JF; Mengod G; Palacios JM; Vilaró MT
Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):446-54. PubMed ID: 9349630
[TBL] [Abstract][Full Text] [Related]
9. Use of [3H]-clozapine as a ligand of the dopamine D4 receptor subtype in peripheral tissues.
Ricci A; Bronzetti E; Rossodivita I; Amenta F
J Auton Pharmacol; 1997 Aug; 17(4):261-7. PubMed ID: 9373785
[TBL] [Abstract][Full Text] [Related]
10. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
[TBL] [Abstract][Full Text] [Related]
11. (Aryloxy)alkylamines as selective human dopamine D4 receptor antagonists: potential antipsychotic agents.
Unangst PC; Capiris T; Connor DT; Doubleday R; Heffner TG; MacKenzie RG; Miller SR; Pugsley TA; Wise LD
J Med Chem; 1997 Dec; 40(25):4026-9. PubMed ID: 9406594
[TBL] [Abstract][Full Text] [Related]
12. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
13. In vivo regulation of serotonin 5-HT2A receptors in rat brain by subchronic administration of sigma receptor ligand NE-100.
Hashimoto K; Narita N; Tomitaka S; Iyo M; Minabe Y
Life Sci; 1997; 60(24):2245-54. PubMed ID: 9188767
[TBL] [Abstract][Full Text] [Related]
14. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Metwally KA; Dukat M; Egan CT; Smith C; DuPre A; Gauthier CB; Herrick-Davis K; Teitler M; Glennon RA
J Med Chem; 1998 Dec; 41(25):5084-93. PubMed ID: 9836624
[TBL] [Abstract][Full Text] [Related]
15. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1.
Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW
J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological characterization and autoradiographic localization of a putative dopamine D4 receptor in the heart.
Ricci A; Bronzetti E; Fedele F; Ferrante F; Zaccheo D; Amenta F
J Auton Pharmacol; 1998 Apr; 18(2):115-21. PubMed ID: 9730266
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D4 receptors may alleviate antipsychotic-induced parkinsonism.
Seeman P; Corbett R; Van Tol HH
Adv Pharmacol; 1998; 42():478-82. PubMed ID: 9327943
[No Abstract] [Full Text] [Related]
18. Neuropharmacological assessment of potential dopamine D4 receptor-selective radioligands.
Kula NS; Tarazi FI; Baldessarini RJ; Xu L; Bakthavachalam V; Pounds S; True CD
Eur J Pharmacol; 1999 Feb; 367(1):139-42. PubMed ID: 10082277
[TBL] [Abstract][Full Text] [Related]
19. Selective alkylatation of dopamine D2 and D4 receptors in rat brain by N-(p-isothiocyanatophenethyl)spiperone.
Zhang K; Tarazi FI; Kula NS; Baldessarini RJ; Neumeyer JL
Neurosci Lett; 1999 Oct; 274(3):155-8. PubMed ID: 10548413
[TBL] [Abstract][Full Text] [Related]
20. Biological profile of L-745,870, a selective antagonist with high affinity for the dopamine D4 receptor.
Patel S; Freedman S; Chapman KL; Emms F; Fletcher AE; Knowles M; Marwood R; Mcallister G; Myers J; Curtis N; Kulagowski JJ; Leeson PD; Ridgill M; Graham M; Matheson S; Rathbone D; Watt AP; Bristow LJ; Rupniak NM; Baskin E; Lynch JJ; Ragan CI
J Pharmacol Exp Ther; 1997 Nov; 283(2):636-47. PubMed ID: 9353380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
